Inhibition by arsenic trioxide of human hepatoma cell growth.

[1]  J. Shen,et al.  The alteration of mitochondria is an early event of arsenic trioxide induced apoptosis in esophageal carcinoma cells. , 2000, International journal of molecular medicine.

[2]  Y. Y. Lee,et al.  Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-1. , 1999, Biochemical and biophysical research communications.

[3]  M. Kuo,et al.  Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells , 1999, British Journal of Cancer.

[4]  E. Cao,et al.  Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide. , 1999, European journal of cancer.

[5]  Yong Ming Li,et al.  Arsenic targets tubulins to induce apoptosis in myeloid leukemia cells. , 1999, Cancer research.

[6]  Shinsuke Suzuki,et al.  Arsenic trioxide inhibits growth of human T‐cell leukaemia virus type I infected T‐cell lines more effectively than retinoic acids , 1998, British journal of haematology.

[7]  R. Ohno,et al.  The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms , 1998, Leukemia.

[8]  Y. Akao,et al.  Arsenic induces apoptosis in B‐cell leukaemic cell lines in vitro: activation of caspases and down‐regulation of Bcl‐2 protein , 1998, British journal of haematology.

[9]  P. Pandolfi,et al.  Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner. , 1998, Blood.

[10]  K. Zhang,et al.  Glutathione-related mechanisms in cellular resistance to anticancer drugs. , 1998, International journal of oncology.

[11]  C. Peschle,et al.  Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells. , 1998, Journal of the National Cancer Institute.

[12]  Y. C. Liu,et al.  Glutathione peroxidase and catalase modulate the genotoxicity of arsenite. , 1997, Toxicology.

[13]  Wei Tang,et al.  Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. , 1997, Blood.

[14]  A. Meister.  Glutathione, ascorbate, and cellular protection. , 1994, Cancer research.

[15]  S. Lu,et al.  Comparison of sulfur amino acid utilization for GSH synthesis between HepG2 cells and cultured rat hepatocytes. , 1994, Biochemical pharmacology.

[16]  T. Lee,et al.  Glutathione S-transferase pi in an arsenic-resistant Chinese hamster ovary cell line. , 1992, The Biochemical journal.

[17]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[18]  A. Meister,et al.  Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). , 1979, The Journal of biological chemistry.

[19]  P. Pandolfi,et al.  Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide , 2001 .

[20]  石塚 賢治.  Arsenic trioxide inhibits growth of human T-cell leukaemia virus type 1 infected T-cell lines more effectively than retinoic acids , 2000 .

[21]  S. Lu.  Regulation of glutathione synthesis. , 2000, Current topics in cellular regulation.

[22]  S. Waxman,et al.  Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. , 1999, Blood.

[23]  Yong-kui,et al.  Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. , 1999, Journal of the National Cancer Institute.

[24]  T. Naoe,et al.  In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. , 1996, Blood.

[25]  G. Wilding,et al.  Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  D. E. Carter,et al.  Reactions of arsenic(III) and arsenic(V) species with glutathione. , 1993, Chemical research in toxicology.